Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging.
about
MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findingsImaging-based tumor treatment response evaluation: review of conventional, new, and emerging conceptsAdvances in molecular imaging for breast cancer detection and characterizationOncologic Angiogenesis Imaging in the clinic---how and why.Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusionAdvanced magnetic resonance imaging of the physical processes in human glioblastoma.The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data.Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.Evaluation of the effect of transcytolemmal water exchange analysis for therapeutic response assessment using DCE-MRI: a comparison studyTargeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumabTemporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancerEarlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survivalFundamentals of tracer kinetics for dynamic contrast-enhanced MRI.Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?Review of treatment assessment using DCE-MRI in breast cancer radiation therapy.Imaging and cancer: a review.Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapyActivity of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid against human head and neck carcinoma xenograftsFunctional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer.Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenibThe role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.Molecular imaging as a tool for translating breast cancer scienceFunctional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancer.Functional MR imaging as a new paradigm for image guidance.Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.Molecular imaging for personalized cancer care.Molecular imaging using PET for breast cancer.Image based modeling of tumor growth.Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results.Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.T2*-relaxivity contrast imaging: first results.A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.Evaluation of therapeutic effect of tumor-targeted therapy.Molecular and clinical aspects of targeting the VEGF pathway in tumors.
P2860
Q26750794-40DEE282-D551-4AC6-9F1D-491AB5C459ABQ26863654-8A0E7E88-15A2-4010-A18F-C64B1F762D4AQ27000462-A365298D-D429-4C93-89B6-14B4711568F5Q30472751-5B47D2B4-BE3B-49A1-AA15-0498838611E6Q30822146-6A4E176B-7864-4920-B8FD-168D7082F8CFQ30847284-CEDDC49E-95F4-424A-8474-9D6D500304D0Q30873526-6DE36C4E-BED2-48D6-98FF-2AF7BE5C660AQ31092479-22B9BBCB-C76C-40B8-898C-FC38434D21FCQ31106171-743096BE-078B-4196-99B0-97315AD7A73CQ33418562-BBEDECAC-77E1-4274-92BC-1EE356B65A49Q33474971-10796EB5-0F1E-4CDB-B033-0B95F151487FQ33781825-716126DA-CB51-48DA-AC26-0DC4110F8F28Q33925521-E22B2E74-2C6E-431E-9E00-C3B5D6B0E210Q34040125-E37D09BF-A256-422E-A80E-8B306A0A42C3Q34256394-277DE5C9-7279-4F9C-9EEF-5D2101E58095Q34367593-41FA519E-88DA-4967-8DF1-28EE5D593F93Q34977050-32B94026-0D79-4FEE-86EB-7056A2ACDE90Q35072927-B68B96C2-8FFE-4E9E-A47B-181DAECBAAECQ35082693-C0B40C4C-4A9B-45C0-93F7-3E66B3108DA3Q35697737-ABE3F634-34AB-4D84-9680-90D658B3E492Q35794860-C48F8005-BD3E-4143-8678-8137236F0D10Q35919459-C419D8BD-FF5D-48B1-AB12-B4463461E3BAQ35926256-1B247027-8CA3-41D3-85B2-44EFB246A94EQ36223538-55094215-AB8C-48ED-B2DB-85FB1C257729Q36457747-49CE4244-3B8C-4BD7-8ED3-8E9090BD950CQ36599503-CC9A77C5-2D9C-4E09-824D-E93F40F59777Q37019264-1D4FB570-8CF5-4AA5-BB1E-E7153A850816Q37272279-203C855B-5AB5-4656-B33C-0C00BC10F269Q37313683-DD26CC9A-B652-43E9-9A25-9FEBBAAF2FD5Q37339028-F52914FD-4B52-4F07-AE95-0857B3C59284Q37562093-96107616-40D8-4E61-8717-A64453B22CF3Q37999206-9F61885C-BBCB-41F0-A6D9-28E070383D8EQ38444869-39022123-235F-4C82-9828-0801D14722E9Q38946715-4D35878D-F140-4CDD-A809-D2C64C7587F9Q38989194-C7F586C8-8157-40ED-B3BC-83C9C3F967A9Q39176990-13FF0A99-EEF9-4D4B-9A22-1E2F2715FBC2Q39325108-2B575D60-6F53-4405-B997-DD0B94A023BEQ41110202-6266CE38-7AFF-479B-96F7-095AD4BC4C48Q41962463-6DD916A4-9B10-4255-B244-8BCA141C4DF4Q42121924-395C1378-1E6D-464D-8A7B-781A8B76C22E
P2860
Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@ast
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@en
type
label
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@ast
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@en
prefLabel
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@ast
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@en
P2860
P1433
P1476
Antivascular cancer treatments ...... ed magnetic resonance imaging.
@en
P2093
P2860
P304
P356
10.1007/S00261-004-0265-5
P577
2005-05-01T00:00:00Z